Effects of Baduanjin on patients with chronic nonspecific low back pain: a randomized controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000003401

Enrollment

Unknown

Registered

2020-06-16

Start date

2020-06-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic nonspecific low back pain

Interventions

Blank control group:Nil

Acupuncture group :Acupuncture treatment

Medicine group:Oral Celebrex capsule

Intervention group:Practicing Baduanjin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of CNLBP, and the duration of low back pain symptoms > 12 weeks; 2. Aged 18~60 years; 3. Cognitive function is normal and can cooperate with related rehabilitation interventions.

Exclusion criteria

Exclusion criteria: 1. Those who have had spinal tuberculosis, space occupation or fracture before undergoing lumbar surgery; 2. Suffering from scoliosis, ankylosing spondylitis, etc.; 3. Primary diseases accompanied by serious infection, hematopoietic system, endocrine system, etc.; 4. Pregnant women or lactating women; 5. Can't cooperate with Baduanjin exercises for various reasons.

Design outcomes

Primary

Measure	Time frame
Balance function;Lumbar MR;Gait;Roland-morris;SF-36 (quality of life scale);VAS;Oswestry disability index;PDT pressure pain data;Lumbar range of motion (ROM);Japanese Orthopaedic Association Scores (JOA);	—

Countries

China

Contacts

Public ContactYang Qingtang

The First Hospital of Nanping City, Fujian Province

2625055232@qq.com+86 18960661357

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026